logo

Astrazeneca plc ADR (AZN) Stock: Uncovering a 52-Week Range and Trading Volume

PNC Stock

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Astrazeneca plc ADR’s current trading price is -12.32% away from its 52-week high, while its distance from the 52-week low is 27.12%. The stock’s price range for this time frame has been between $60.47 and $87.68. The trading volume of the company’s shares in the Healthcare reached around 4.3 million for the day, which was evidently lower than the average daily volume of 4.38 million over the last three months.

Astrazeneca plc ADR’s stock has had a calm market performance. The 1-year high for the company’s stock was $87.68 on 08/30/24, and the lowest price during the same period was recorded at $60.47 on 02/12/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -3.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 238.34B and boasts a workforce of 89900 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 79.83, with a change in price of +0.46. Similarly, Astrazeneca plc ADR recorded 4,344,212 in trading volume during the last 100 days, posting a change of +0.60%.

How AZN’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.85. Similarly, the long-term debt-to-equity ratio is also 0.71.

AZN Stock Stochastic Average

The raw stochastic average for Astrazeneca plc ADR over the last 50 days is presently at 3.66%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 0.37%. Further, the company’s Stochastic %K and %D values for the last 20 days were 2.83% and 6.30%, respectively.

AZN Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 14.14%. However, over the past six months, we’ve seen a weaker performance of 16.72%. The price of AZN leaped by -11.30% over the last 30 days. And in the last five days, it has fallen by -2.11%.

Most Popular